Dallas, TX (PRWEB) March 12, 2013
This comprehensive market report has primarily focused on quantitative market metrics in order to characterize the growth and evolution of the cellular therapy field--in this vein. The report provides primary industry data that it has collected as part of its continual industry tracking of this space.
The report analysis clinical trial trends and the evolution of several therapeutics areas within cellular therapy [orthopedic, skin/wound care, cardiovascular, and CNS disorders] and present the current status of every single program within the preclinical through the various clinical trial phases and onto commercialization. The report also presents the breakout of clinical trials in the bonafide cellular therapy sector with respect to geographic breakout, breakout by type of cells utilized, and disease classes interrogated.
The report “Cellular Therapy and Cord Blood 2013 Market Report” also provides a detailed quantitative analysis of the cord blood field as it is rapidly evolving. The report provides hard numbers on sizes of the various registries, the TNC breakouts of banked units, detailed cost breakouts for banking as well as HSCTs utilizing cord blood. Furthermore, the report has been able to compare the EU and US markets side-by-side in this analysis.
The report also presents the ATMP regulatory guidelines governing the marketing authorization of cellular therapeutics in the European Union. Details on the statute as well as implications to companies seeking to navigate this space are provided.
Extensive Market Analyses Presented in this Report:
Copyright©2012 Vocus, Inc.
All rights reserved